Viable SARS-CoV-2 virus was detected in immunocompromised cancer patients with COVID-19 for up to two months after symptom onset, a small study found.
Out of 20 cancer patients with COVID-19 and suppressed immune function, three continued to shed culturable virus for more than 20 days, reported Mini Kamboj, MD, of Memorial Sloan Kettering Cancer Center in New York City, and colleagues.
More: MedPage Today